CBX5 Knockout Raji Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population designed to disrupt CBX5 (heterochromatin protein 1 ??, HP1??) expression in the human Raji B lymphocyte line. This heterogeneous loss-of-function pool enables population-level studies without clonal bias, serving as a robust model for investigating HP1??-dependent processes.
The parental Raji cell line is an EBV-positive Burkitt lymphoma model of B lymphocyte origin, widely used to study B cell receptor signaling, antigen presentation, and lymphomagenesis. Its well-characterized growth and chromatin landscape provide a relevant system for examining epigenetic regulators in B-cell malignancies.
CBX5 encodes a conserved reader of trimethylated histone H3 at lysine 9 (H3K9me3). Through its chromodomain, HP1?? dimerizes and recruits effectors including SUV39H1, TRIM28/KAP1, DNMT1, and CAF-1 to propagate heterochromatin formation and gene silencing. HP1?? activity is modulated by H3K9 methyltransferases (SUV39H1, SUV39H2, SETDB1), CK2- and PKA-mediated phosphorylation, and ATM/ATR-dependent DNA damage signaling. Downstream, CBX5 represses tumor suppressors p16INK4a (CDKN2A) and p21 (CDKN1A) while influencing DNA repair pathway choice and telomere maintenance. Interactions with lamin B receptor and HDAC1/2 further link HP1?? to chromatin organization and epigenetic stability.
In Raji B lymphoma cells, CBX5-dependent heterochromatin formation interfaces with pathways central to malignancy and immune function. Disrupting CBX5 permits dissection of how H3K9me3-mediated silencing influences B cell receptor signaling dynamics, antigen presentation gene expression, and survival programs in EBV-driven lymphomagenesis. Because CBX5 participates in DNA damage responses and senescence bypass, its knockout in this model is particularly relevant for probing resistance mechanisms to genotoxic therapies and for identifying synthetic vulnerabilities in chromatin-dysregulated lymphomas.
Key experimental applications include chromatin immunoprecipitation (ChIP-qPCR) to map H3K9me3 and HP1?? occupancy changes, RNA-seq for global transcriptome profiling, and immunofluorescence to visualize heterochromatin foci disruption. Functional studies can employ flow cytometry for apoptosis and cell cycle analysis, Western blotting to confirm CBX5 ablation and pathway alterations, and drug sensitivity assays with HDAC inhibitors or DNA-damaging agents. This polyclonal knockout population is an essential tool for researchers investigating epigenetic gene silencing, DNA repair, and B-cell malignancy. For further information, please contact Ascent Research.
